2025-02-04 - Analysis Report
## Nike Inc. (NKE) Stock Report

**0) Executive Summary:**

Nike Inc. (NKE), a global leader in athletic footwear and apparel, shows significantly underperformed against the S&P 500 (VOO) over the given period. While recent financial reports indicate strong revenue and profitability, negative CAGR and concerning recent price movement raise concerns about future performance.  Further investigation into the causes of the underperformance is needed.


**1) Performance Comparison & Alpha/Beta Analysis:**

Nike Inc. (NKE) is a global sportswear giant designing, developing, and marketing athletic footwear, apparel, equipment, and accessories.

* **Cumulative Return:** NKE: 3.62%; VOO: 119.91%
* **Return Difference:** NKE underperformed VOO by approximately 116.3 percentage points.  The relative divergence places NKE at the 3.4th percentile of its historical performance against the S&P 500, indicating significant underperformance.

The provided Alpha/Beta analysis shows wildly fluctuating performance and a high beta (often exceeding 1), indicating high sensitivity to market movements.  The negative CAGRs in recent years (2021-2025) are particularly alarming.  While some periods show strong alpha (outperformance),  the overall trend suggests significant risk and inconsistent performance.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 17.0% | 7.7% | -11.0% | 0.0 | 85.1 |
| 2016-2018  | 14.0% | 10.1% | -4.0% | 0.1 | 102.0 |
| 2017-2019  | 70.0% | 10.7% | 40.0% | 0.6 | 140.8 |
| 2018-2020  | 94.0% | 10.7% | 67.0% | 0.4 | 198.6 |
| 2019-2021  | 98.0% | 11.3% | 27.0% | 0.4 | 235.7 |
| 2020-2022  | 4.0% | 21.1% | -5.0% | 0.4 | 167.2 |
| 2021-2023  | -60.0% | 21.1% | -83.0% | 1.4 | 157.2 |
| 2022-2024  | -110.0% | 21.1% | -143.0% | 1.1 | 111.4 |
| 2023-2025  | -72.0% | 19.9% | -0.3 | 113.2 |


**2) Recent Price Movement:**

* **Closing Price:** $76.90
* **Last Market Price:** $76.57 (a decrease of $0.435 or -0.57%)
* **5-Day Moving Average:** $76.36
* **20-Day Moving Average:** $73.33
* **60-Day Moving Average:** $75.63

The price is slightly below the 5-day and 60-day moving averages, but significantly above the 20-day moving average, suggesting some short-term weakness but potential for recovery.


**3) Technical Indicators & Expected Return:**

* **RSI:** 69.08 (Approaching overbought territory)
* **PPO:** 1.02 (Positive, suggesting upward momentum)
* **Recent Relative Divergence:** +3.4 (Short-term upward trend)
* **Expected Return:** -349.4% (This exceptionally negative figure requires further clarification and context.  It likely reflects a comparison against a very high baseline or an error in calculation.)

The recent price drop (-0.435) is relatively small and doesn't suggest a significant immediate event (no "급반등" or "급하락").


**4) Recent Earnings Analysis:**

The earnings data shows some volatility, but overall revenue generally remains strong.  There's an apparent anomaly in the data with the same EPS and revenue repeated for 2024-01-05 and 2025-01-03; clarification is needed.

| Date       | EPS  | Revenue       |
|------------|------|----------------|
| 2025-01-03 | 0.78 | $12.35 B       |
| 2024-10-07 | 0.70 | $11.59 B       |
| 2024-04-04 | 0.77 | $12.43 B       |
| 2024-01-05 | 1.04 | $13.39 B       |
| 2025-01-03 | 1.04 | $13.39 B       |


**5) Financial Information:**

Revenue shows some fluctuations but remains consistently high.  Profit margins are healthy and relatively stable.  Equity is generally stable, while ROE fluctuates but remains generally positive, although it has declined in the last two quarters.

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-11-30 | $12.35B | 43.62% |
| 2024-08-31 | $11.59B | 45.36% |
| 2024-05-31 | $12.61B | 44.69% |
| 2024-02-29 | $12.43B | 44.75% |
| 2023-11-30 | $13.39B | 44.60% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-11-30 | $14.04B | 8.29% |
| 2024-08-31 | $13.94B | 7.54% |
| 2024-05-31 | $14.43B | 10.40% |
| 2024-02-29 | $14.23B | 8.24% |
| 2023-11-30 | $14.15B | 11.16% |


**6) Overall Analysis:**

Nike's recent financial performance displays a mixed picture. While revenue and profit margins remain strong, the substantial underperformance against the S&P 500, highly volatile CAGR and beta, and an extremely negative projected long-term return raise significant concerns. The seemingly inconsistent earnings data requires further investigation and clarification.  The negative CAGR figures for the past few years are the most significant warning sign. Before making any investment decisions, a thorough analysis of the underlying reasons for this underperformance – including macro-economic factors, competitive pressures, and company-specific issues – is crucial.  The -349.4% expected return figure needs to be reviewed and validated to ensure accuracy.
